Latest Content

Topical HT-001 reduced rash and irritation from EGFR therapies with low levels in the bloodstream and no serious side effects in patients with cancer.

A son shares his decision to become a living liver donor, offering his father a second chance after a cancer diagnosis.

Dr. Amengual outlines how patients with relapsed lymphoma can approach clinical trials, including phases, eligibility and key questions to ask providers.

A couple shares how self advocacy, preparation and caregiver support shaped their experience navigating liver cancer care.

Dr. Wendy Woodward discussed the transformative rise of hypofractionated radiation.

The FDA approved a steroid-sparing Tecvayli and Darzalex Faspro combo for relapsed myeloma, offering an 83% reduction in disease progression risk.

Jonise S. Louis shares her journey of navigating a metastatic breast cancer diagnosis and chemotherapy while pregnant with the help of her oncology team.

Zegfrovy helped patients live longer without cancer growth and improved tumor response compared with chemotherapy in first-line lung cancer treatment.

A living liver donor shares recovery, fatigue and the lasting reward of helping his father heal after transplant surgery.

Dr. Hope Rugo and advocate Jonise Louis discuss new ADCs, biomarker testing, and patient-centered dosing for metastatic triple-negative breast cancer.

High-risk essential thrombocythemia is manageable with treatment focused on preventing blood clots and maintaining safe platelet levels.

After a liver cancer diagnosis, one son stepped forward as a living donor, turning uncertainty into hope through a life-saving decision.

Functional precision medicine uses a patient’s tumor cells to test drugs, helping guide more personalized brain tumor treatment decisions.